145 related articles for article (PubMed ID: 33502001)
1. Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene.
Wouters Y; Nevejan L; Louwagie A; Devos H; Dewaele B; Selleslag D; Michaux L
Br J Haematol; 2021 Feb; 192(4):e112-e115. PubMed ID: 33502001
[No Abstract] [Full Text] [Related]
2. Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.
Schewe DM; Lenk L; Vogiatzi F; Winterberg D; Rademacher AV; Buchmann S; Henry D; Bergmann AK; Cario G; Cox MC
Blood Adv; 2019 Nov; 3(22):3499-3502. PubMed ID: 31725893
[TBL] [Abstract][Full Text] [Related]
3. Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with novel NPHP3-JAK2 fusion.
Chen X; Yuan L; Zhou J; Wang F; Zhang Y; Ma X; Cao P; Fang J; Chen J; Zhou X; Wu Q; Liu M; Liu H
Genes Chromosomes Cancer; 2022 Jan; 61(1):55-58. PubMed ID: 34418218
[No Abstract] [Full Text] [Related]
4. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and
Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402
[TBL] [Abstract][Full Text] [Related]
5. New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.
Moorman AV
Haematologica; 2016 Apr; 101(4):407-16. PubMed ID: 27033238
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.
Rumi E; Milosevic JD; Selleslag D; Casetti I; Lierman E; Pietra D; Cavalloni C; Bellini M; Milanesi C; Dambruoso I; Astori C; Kralovics R; Vandenberghe P; Cazzola M
Ann Hematol; 2015 Nov; 94(11):1927-8. PubMed ID: 26202607
[No Abstract] [Full Text] [Related]
7. Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia.
Downes CEJ; Rehn J; Heatley SL; Yeung D; McClure BJ; White DL
Br J Haematol; 2022 Feb; 196(3):700-705. PubMed ID: 34697799
[TBL] [Abstract][Full Text] [Related]
8. Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.
Mayfield JR; Czuchlewski DR; Gale JM; Matlawska-Wasowska K; Vasef MA; Nickl C; Pickett G; Ness SA; Winter SS
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27860260
[TBL] [Abstract][Full Text] [Related]
9. Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.
Schwaab J; Knut M; Haferlach C; Metzgeroth G; Horny HP; Chase A; Tapper W; Score J; Waghorn K; Naumann N; Jawhar M; Fabarius A; Hofmann WK; Cross NC; Reiter A
Ann Hematol; 2015 Feb; 94(2):233-8. PubMed ID: 25260694
[TBL] [Abstract][Full Text] [Related]
10. Emergence of a prominent myeloid clone in a ZNF384-rearranged B-cell precursor acute lymphoblastic leukaemia post-corticosteroid pre-phase therapy.
Kapadia AB; Sreedharanunni S; Muhammed S; Karmakar I; Rana S; Sharma P; Sachdeva MUS; Trehan A
Pediatr Blood Cancer; 2020 Dec; 67(12):e28513. PubMed ID: 32686312
[No Abstract] [Full Text] [Related]
11. Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with
Aldoss I; Pullarkat V
Leuk Lymphoma; 2019 Nov; 60(11):2832-2834. PubMed ID: 31014138
[No Abstract] [Full Text] [Related]
12. The first case of elderly
Takeda R; Yokoyama K; Ogawa M; Kawamata T; Fukuyama T; Kondoh K; Takei T; Nakamura S; Ito M; Yusa N; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
Leuk Lymphoma; 2019 Nov; 60(11):2821-2824. PubMed ID: 31058556
[No Abstract] [Full Text] [Related]
13. Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with
Ding YY; Stern JW; Jubelirer TF; Wertheim GB; Lin F; Chang F; Gu Z; Mullighan CG; Li Y; Harvey RC; Chen IM; Willman CL; Hunger SP; Li MM; Tasian SK
Haematologica; 2018 Sep; 103(9):e427-e431. PubMed ID: 29773603
[No Abstract] [Full Text] [Related]
14. NUP98 rearrangement in B lymphoblastic leukemia with hyperdiploidy.
Liu H
Blood; 2020 Aug; 136(8):1011. PubMed ID: 32818249
[No Abstract] [Full Text] [Related]
15. Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.
Perwein T; Strehl S; König M; Lackner H; Panzer-Grümayer R; Mann G; Attarbaschi A; Urban EC; Haas OA
Haematologica; 2016 Aug; 101(8):e332-5. PubMed ID: 27125982
[No Abstract] [Full Text] [Related]
16. Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.
Rumi E; Milosevic JD; Casetti I; Dambruoso I; Pietra D; Boveri E; Boni M; Bernasconi P; Passamonti F; Kralovics R; Cazzola M
J Clin Oncol; 2013 Jun; 31(17):e269-71. PubMed ID: 23630205
[No Abstract] [Full Text] [Related]
17. Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia.
Gordon MJ; Raess PW; Young K; Spurgeon SEF; Danilov AV
Br J Haematol; 2017 Nov; 179(3):501-503. PubMed ID: 27391978
[No Abstract] [Full Text] [Related]
18. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Reiter A; Walz C; Watmore A; Schoch C; Blau I; Schlegelberger B; Berger U; Telford N; Aruliah S; Yin JA; Vanstraelen D; Barker HF; Taylor PC; O'Driscoll A; Benedetti F; Rudolph C; Kolb HJ; Hochhaus A; Hehlmann R; Chase A; Cross NC
Cancer Res; 2005 Apr; 65(7):2662-7. PubMed ID: 15805263
[TBL] [Abstract][Full Text] [Related]
19. Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.
Eyre T; Schwab CJ; Kinstrie R; McGuire AK; Strefford J; Peniket A; Mead A; Littlewood T; Holyoake TL; Copland M; Moorman AV; Harrison CJ; Vyas P
Blood; 2012 Nov; 120(22):4441-3. PubMed ID: 23175662
[No Abstract] [Full Text] [Related]
20. Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia.
Lierman E; Selleslag D; Smits S; Billiet J; Vandenberghe P
Blood; 2012 Aug; 120(7):1529-31. PubMed ID: 22899477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
